Madrigal Pharmaceuticals Inc (MDGL)
210.82
+6.80
(+3.33%)
USD |
NASDAQ |
May 01, 16:00
210.82
0.00 (0.00%)
After-Hours: 17:03
Madrigal Pharmaceuticals Shareholders Equity (Quarterly): 405.33M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 405.33M |
September 30, 2023 | 22.25M |
June 30, 2023 | 103.51M |
March 31, 2023 | 150.14M |
December 31, 2022 | 197.39M |
September 30, 2022 | 10.67M |
June 30, 2022 | 83.54M |
March 31, 2022 | 145.74M |
December 31, 2021 | 196.11M |
September 30, 2021 | 234.88M |
June 30, 2021 | 270.65M |
March 31, 2021 | 260.55M |
December 31, 2020 | 239.97M |
September 30, 2020 | 289.70M |
June 30, 2020 | 342.92M |
March 31, 2020 | 385.48M |
December 31, 2019 | 416.56M |
September 30, 2019 | 440.35M |
June 30, 2019 | 456.99M |
March 31, 2019 | 468.51M |
December 31, 2018 | 476.98M |
September 30, 2018 | 482.91M |
June 30, 2018 | 486.09M |
March 31, 2018 | 177.18M |
December 31, 2017 | 182.26M |
Date | Value |
---|---|
September 30, 2017 | 54.31M |
June 30, 2017 | 61.63M |
March 31, 2017 | 34.45M |
December 31, 2016 | 36.41M |
September 30, 2016 | 37.59M |
June 30, 2016 | 41.57M |
March 31, 2016 | 44.33M |
December 31, 2015 | -48.91M |
September 30, 2015 | 60.37M |
June 30, 2015 | 68.98M |
March 31, 2015 | 46.14M |
December 31, 2014 | 65.14M |
September 30, 2014 | 83.73M |
June 30, 2014 | 74.00M |
March 31, 2014 | 38.22M |
December 31, 2013 | 49.09M |
September 30, 2013 | 14.61M |
June 30, 2013 | 35.44M |
March 31, 2013 | 56.60M |
December 31, 2012 | 75.07M |
September 30, 2012 | 32.19M |
June 30, 2012 | 20.46M |
March 31, 2012 | 33.77M |
December 31, 2011 | 14.77M |
September 30, 2011 | 24.58M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.67M
Minimum
Sep 2022
456.99M
Maximum
Jun 2019
244.88M
Average
239.97M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 10.77B |
Viking Therapeutics Inc | 933.89M |
Akero Therapeutics Inc | 535.31M |
89bio Inc | 536.31M |
Geron Corp | 247.95M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 640.55M |
Total Liabilities (Quarterly) | 235.21M |